Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ted M Burns

Showing results (71-80 of 90) with videos related to

Pageof 9
Sort By:
Muscle & Nerve|May 15, 2012
Recommendations for myasthenia gravis clinical trialsMichael Benatar, Donald B Sanders, Ted M Burns, et al.
Journal of the Peripheral Nervous System : JPNS|November 18, 2014
Psychometrics evaluation of Charcot-Marie-Tooth Neuropathy Score (CMTNSv2) second version, using Rasch analysisReza Sadjadi, Mary M Reilly, Michael E Shy, et al.
Amyotrophic Lateral Sclerosis : Official Publication of the World Federation of Neurology Research Group on Motor Neuron Diseases|February 14, 2008
R+ pramipexole as a mitochondrially focused neuroprotectant: initial early phase studies in ALSHua Wang, Kylyana S Larriviere, Kristen E Keller, et al.
The Lancet. Neurology|October 26, 2017
Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre studyJames F Howard, Kimiaki Utsugisawa, Michael Benatar, et al.
Muscle & Nerve|May 21, 2019
Investigation of the psychometric properties of the inclusion body myositis functional rating scale with rasch analysisGita Ramdharry, Jasper Morrow, Stacie Hudgens, et al.
Muscle & Nerve|November 26, 2013
Electrical impedance myography correlates with standard measures of ALS severitySeward B Rutkove, James B Caress, Michael S Cartwright, et al.
Muscle & Nerve|November 25, 2015
Construction and validation of the chronic acquired polyneuropathy patient-reported index (CAP-PRI): A disease-specific, health-related quality-of-life instrumentKelly G Gwathmey, Mark R Conaway, Reza Sadjadi, et al.
Neurology|May 10, 2020
Validation of serum neurofilaments as prognostic and potential pharmacodynamic biomarkers for ALSMichael Benatar, Lanyu Zhang, Lily Wang, et al.
Amyotrophic Lateral Sclerosis : Official Publication of the World Federation of Neurology Research Group on Motor Neuron Diseases|June 8, 2012
Electrical impedance myography as a biomarker to assess ALS progressionSeward B Rutkove, James B Caress, Michael S Cartwright, et al.
Muscle & Nerve|February 16, 2019
Long-term safety and efficacy of eculizumab in generalized myasthenia gravisSrikanth Muppidi, Kimiaki Utsugisawa, Michael Benatar, et al.
Pageof 9

Showing results (71-80 of 90) with videos related to

Sort By:
Pageof 9
Muscle & Nerve|May 15, 2012
Recommendations for myasthenia gravis clinical trialsMichael Benatar, Donald B Sanders, Ted M Burns, et al.
Journal of the Peripheral Nervous System : JPNS|November 18, 2014
Psychometrics evaluation of Charcot-Marie-Tooth Neuropathy Score (CMTNSv2) second version, using Rasch analysisReza Sadjadi, Mary M Reilly, Michael E Shy, et al.
Amyotrophic Lateral Sclerosis : Official Publication of the World Federation of Neurology Research Group on Motor Neuron Diseases|February 14, 2008
R+ pramipexole as a mitochondrially focused neuroprotectant: initial early phase studies in ALSHua Wang, Kylyana S Larriviere, Kristen E Keller, et al.
The Lancet. Neurology|October 26, 2017
Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre studyJames F Howard, Kimiaki Utsugisawa, Michael Benatar, et al.
Muscle & Nerve|May 21, 2019
Investigation of the psychometric properties of the inclusion body myositis functional rating scale with rasch analysisGita Ramdharry, Jasper Morrow, Stacie Hudgens, et al.
Muscle & Nerve|November 26, 2013
Electrical impedance myography correlates with standard measures of ALS severitySeward B Rutkove, James B Caress, Michael S Cartwright, et al.
Muscle & Nerve|November 25, 2015
Construction and validation of the chronic acquired polyneuropathy patient-reported index (CAP-PRI): A disease-specific, health-related quality-of-life instrumentKelly G Gwathmey, Mark R Conaway, Reza Sadjadi, et al.
Neurology|May 10, 2020
Validation of serum neurofilaments as prognostic and potential pharmacodynamic biomarkers for ALSMichael Benatar, Lanyu Zhang, Lily Wang, et al.
Amyotrophic Lateral Sclerosis : Official Publication of the World Federation of Neurology Research Group on Motor Neuron Diseases|June 8, 2012
Electrical impedance myography as a biomarker to assess ALS progressionSeward B Rutkove, James B Caress, Michael S Cartwright, et al.
Muscle & Nerve|February 16, 2019
Long-term safety and efficacy of eculizumab in generalized myasthenia gravisSrikanth Muppidi, Kimiaki Utsugisawa, Michael Benatar, et al.
Pageof 9